Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany

Efficacy and tolerability of fenfluramine in patients with Dravet syndrome: A systematic review and meta-analysis

(2021) Indar Kumar Sharawat et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder

(2021) Orrin Devinsky et al.   EPILEPSIA

Fenfluramine acts as a positive modulator of sigma-1 receptors

(2020) Parthena Martin et al.   EPILEPSY & BEHAVIOR

Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study

(2020) Wyman W. Lai et al.   EPILEPSIA

Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real‐world study

(2020) Nicola Specchio et al.   EPILEPSIA

Fenfluramine HCl (Fintepla ® ) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study

(2020) Joseph Sullivan et al.   EPILEPSIA

Therapeutic advances in Dravet syndrome: a targeted literature review

(2020) Adam Strzelczyk et al.   Expert Review of Neurotherapeutics

Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population‐based study on German health insurance data

(2019) Susanne Schubert‐Bast et al.   EPILEPSIA

A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany

(2019) Adam Strzelczyk et al.   EPILEPSIA

Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literature

(2019) Susanne Schubert-Bast et al.   EPILEPSY & BEHAVIOR

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

(2019) Lieven Lagae et al.   LANCET

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens

(2019) Rima Nabbout et al.   JAMA Neurology

Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

(2017) Robert S. Fisher et al.   EPILEPSIA

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

(2017) Ingrid E. Scheffer et al.   EPILEPSIA

Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine

(2016) Berten Ceulemans et al.   EPILEPSIA

Mortality in Dravet syndrome

(2016) Monica S. Cooper et al.   EPILEPSY RESEARCH

Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients

(2016) A. Schoonjans et al.   EUROPEAN JOURNAL OF NEUROLOGY

A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus

(2015) Eugen Trinka et al.   EPILEPSIA

Successful use of fenfluramine as an add-on treatment for Dravet syndrome

(2012) Berten Ceulemans et al.   EPILEPSIA